3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
3
CNS
1
Conditions
Brain Neoplasms
12
Meningioma
6
Glioma
6
Glioblastoma
4
Pituitary Neoplasms
2
Pinealoma
2
Oligodendroglioma
2
Gliosarcoma
2
Craniopharyngioma
2
Astrocytoma
2
Prostatic Neoplasms
1
Neuroblastoma
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Medulloblastoma
1
Malignant Brain Glioma
1
Hemangiopericytoma
1
Head and Neck Neoplasms
1
Ganglioneuroblastoma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Docetaxel
7
Radiotherapy
6
Filgrastim
6
Cisplatin
4
Peripheral Blood Stem Cell Transplantation
3
Chemotherapy, Adjuvant
3
Carboplatin
3
selpercatinib
2
sargramostim
2
Thiotepa
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Nivolumab
2
Gemcitabine
2
Etoposide
2
Drug Therapy
2
Doxorubicin
2
Capecitabine
2
Biopsy
2
Acupuncture Therapy
2
vocimagene amiretrorepvec
1
vandetanib
1
ulixertinib
1
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tanespimycin
1
spartalizumab
1
pentetreotide
1
pazopanib
1
oncogene protein E7, Human papillomavirus type 16
1
oblimersen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Proton Therapy
×
CNS
×
Clear all
NCT05549414
2023-07-10
PPTS
P-Cure
Phase NA
Unknown
100 enrolled